Welcome to our dedicated page for Sintx Technologies news (Ticker: SINT), a resource for investors and traders seeking the latest updates and insights on Sintx Technologies stock.
SINTX Technologies Inc (SINT) delivers cutting-edge advanced ceramics solutions for critical biomedical and industrial applications through its silicon nitride expertise. This news hub provides investors and industry professionals with essential updates on the company’s material science innovations, regulatory milestones, and market developments.
Access real-time announcements covering earnings reports, product launches, strategic partnerships, and research breakthroughs in antimicrobial ceramics technology. Our curated collection simplifies tracking SINTX’s progress in spinal implant advancements, industrial material innovations, and antipathogenic surface solutions.
Key updates across three focus areas: Medical Device Developments (FDA-cleared implants, clinical trial results), Technical Ceramics Innovation (3D printing materials, industrial components), and Corporate Strategy (partnerships, financial performance). Bookmark this page for streamlined monitoring of SINTX’s role in advancing ceramics technology across healthcare and manufacturing sectors.
SINTX Technologies has completed renovations and equipment installation at its SINTX Armor facility in Salt Lake City, enhancing its capacity to manufacture high-performance ceramic armor products for personnel, aircraft, and vehicles. This facility spans 10,000 square feet and produces advanced materials like BoroShock and DuraShock, which offer lightweight, high-strength protection against projectiles. Following a strategic acquisition of B4C LLC, SINTX Armor anticipates a strong order book in 2023, aligning with a projected global ceramic armor market growth to USD $3.5 billion by 2027.
SINTX Technologies, Inc. (NASDAQ: SINT) has announced a public offering of 2,150,000 units, priced at $5.60 each. Each unit consists of one share of common stock or one pre-funded warrant, along with one Class C Warrant and half of one Class D Warrant. The offering is expected to yield approximately $12 million in gross proceeds before expenses and is anticipated to close on February 10, 2023. The securities are offered under SEC regulations, and Maxim Group LLC is serving as the placement agent. SINTX focuses on advanced ceramics, particularly silicon nitride, for medical applications and has a history of product implantation since 2008.
SINTX Technologies reported preliminary unaudited financial results for Q4 2022 and the full year, highlighting a revenue of approximately $770k in Q4 and $1.6 million for the year. This marks a consistent quarter-on-quarter growth, surpassing previous annual revenues since selling its spine business in 2018. Government contracts contributed $521k in Q4 and $962k for the year, while commercial revenue from aerospace, energy, dental, and spine sectors reached $248k in Q4 and $602k annually. The company expects growth in 2023 and anticipates the Armor facility in Salt Lake City to be operational by Q1.
FAQ
What is the current stock price of Sintx Technologies (SINT)?
What is the market cap of Sintx Technologies (SINT)?
